Abstract

This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies in arrhythmia management. The range of digital medical tools and heart rhythm disorders that they may be applied to and clinical decisions that may be enabled are discussed. The facilitation of comorbidity and lifestyle management (increasingly recognized to play a role in heart rhythm disorders) and patient self-management are novel aspects of mHealth. The promises of predictive analytics but also operational challenges in embedding mHealth into routine clinical care are explored.

Highlights

  • This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies in arrhythmia management

  • Utilization of these devices has proliferated among health-conscious consumers in recent years and is likely to continue rapid expansion and integration into more formalized medical settings. mHealth flows intuitively to health professionals in the field of arrhythmia management from experience gained through remote monitoring of cardiovascular implantable electronic devices (CIEDs), such as pacemakers and implantable cardioverter-defibrillators (ICDs) (Varma 2010)

  • The results indicated that this was a feasible frequent continuous monitoring approach for the screening and early detection of atrial fibrillation (AF) in a large population

Read more

Summary

Limitations

One requirement for these technologies is steady focus: moving subjects present a challenge. Video-based technologies in telemedicine have raised a new set of societal and ethical concerns that are being continuously re-evaluated such as during the COVID-19 pandemic. Confidentiality, and legal and ethical obligation to treat are crucial factors to be considered when these technologies are deployed at larger scale (Turakhia 2019). Identification of abnormal heart rate patterns may be made possible by converting smart speakers into a sonar device with emission of in-audible frequencies sound waves and receiving them to detect motion. These are not in consumer domain but potentially have wide scalability

Section 1
Non-ECG-based
Section 2
Targeted identification in high-risk individuals
Atrial fibrillation therapy
Section 3
Comorbidities
Study design and tested modality
Section 4
Patient Self-Management—Integrated Chronic Care
Section 5
Section 6
Section 7
Predictive Analytics
Section 8
Section 9
Findings
5: American Heart
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.